Literature DB >> 9464949

Patterns of failure in differentiated carcinoma of the thyroid based on risk groups.

A R Shaha1, J P Shah, T R Loree.   

Abstract

BACKGROUND: Risk-group stratification based on prognostic factors is well established in differentiated carcinoma of the thyroid gland. Patients in the low-risk group have an excellent prognosis, whereas there is significant mortality associated with the high-risk group. The purpose of this paper is to analyze the patterns of treatment failure in the various (local, regional, distant, and associated mortality) risk groups.
METHODS: In a retrospective review of a consecutive series of 1038 previously untreated patients with differentiated carcinoma of the thyroid during a period of 55 years, various prognostic factors and risk groups were analyzed. Significant prognostic factors were patient's age, presence of distant metastasis, extrathyroid extension, size, and grade of the tumor. Based on these factors, patients were divided into low- (39%), intermediate- (39%), and high- (22%) risk groups.
RESULTS: The overall treatment-failure rates in the low-, intermediate-, and high-risk groups were 13%, 26%, and 50%, respectively, whereas the mortality rates in the same groups were 1%, 10%, and 33%, respectively.
CONCLUSIONS: The overall incidence of recurrence rate in the low-risk group is only 13%, compared with 50% in the high-risk group. The incidence of distant metastasis in the low-risk group is only 2%, compared with 34% in the high-risk group. The understanding of the patterns of treatment failure in different risk groups reaffirms the need to direct treatment strategies based on individual risk groups and intraoperative findings.

Entities:  

Mesh:

Year:  1998        PMID: 9464949     DOI: 10.1002/(sici)1097-0347(199801)20:1<26::aid-hed5>3.0.co;2-5

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression.

Authors:  Alexander Abrosimov; Vladimir Saenko; Serik Meirmanov; Masahiro Nakashima; Tatiana Rogounovitch; Olesya Shkurko; Eugeny Lushnikov; Norisato Mitsutake; Hiroyuki Namba; Shunichi Yamashita
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

2.  Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.

Authors:  Xiao-Shan Min; Peng Huang; Xu Liu; Chao Dong; Xiao-Lin Jiang; Zheng-Tai Yuan; Lin-Feng Mao; Shi Chang
Journal:  Tumour Biol       Date:  2015-04-24

3.  MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.

Authors:  Kepal N Patel; Ellie Maghami; Volkert B Wreesmann; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Bhuvanesh Singh
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

4.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

5.  The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer.

Authors:  Iain J Nixon; Ian Ganly; Snehal Patel; Frank L Palmer; Monica M Whitcher; Robert M Tuttle; Ashok R Shaha; Jatin P Shah
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

6.  Prognostic values of thyroid tumours.

Authors:  Suzana Manxhuka-Kerliu; Emine Devolli-Disha; Arsim Gerxhaliu; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Hajdin Thaqi
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

7.  MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.

Authors:  Lei Dai; Yaozong Wang; Liangliang Chen; Jueru Zheng; Jianjun Li; Xianjiang Wu
Journal:  World J Surg Oncol       Date:  2017-01-07       Impact factor: 2.754

8.  Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer.

Authors:  Jeanny Kwon; Hong-Gyun Wu; Yeo-Kyu Youn; Kyu Eun Lee; Kwang Hyun Kim; Do Joon Park
Journal:  Radiat Oncol J       Date:  2013-09-30

9.  Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

Authors:  Aline de Oliveira Ribeiro Viana; João Gonçalves Filho; Ana Lúcia Noronha Francisco; Clóvis Antônio Lopes Pinto; Luiz Paulo Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06       Impact factor: 2.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.